Form D · Other Health Care
Code Biotherapeutics, Inc.
Hatfield, PA · CIK 0001852269
Offering snapshot reported Jun 9, 2022 · SEC filing
- Reported sold
- $37.5M Offering amount: $75M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2022 | Initial | $37,499,995 | No comparison | 10 | SEC filing |
| Apr 21, 2021 | Amendment | $10,000,000 | $5,000,002vs Mar 22, 2021 | 6 | SEC filing |
| Mar 22, 2021 | Initial | $4,999,998 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448615
Source: Form D, filed Jun 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erin Brubaker | Executive |
| Russ Fein | Director, Executive |
| Robert C Getts | Executive |
| Lauren Kaskiel | Executive |
| Dmitry Kuzmin | Director |
| Robert Lin | Director |
| Edward Mathers | Director |
| Brian Mc Veigh | Director, Executive |
| Kathy Rouan | Director |
| Victor Stone | Director |
| Joseph Truitt | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2801 Sterling Drive
Hatfield, PA, 19440
Hatfield, PA, 19440